Skip to main content

and
  1. Article

    Open Access

    Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers

    Overexpression of MYC oncogene is highly prevalent in many malignancies such as aggressive triple-negative breast cancers (TNBCs) and it is associated with very poor outcome. Despite decades of research, attempts...

    Edina Wang, Anabel Sorolla, Paula T. Cunningham, Heique M. Bogdawa, Samuel Beck in Oncogene (2019)